In this review, we discuss the UGT system and its protective role against bladder cancer, UGT genetic mutations that modulate risk from chemicals and environmental toxins, as well as targeting of the UGT enzymes by nuclear receptors. The gene discussed is SLC35A2; the disease is urinary bladder carcinoma.